Drugs (psychoactive): Cannabidiol (compound of cannabis)
Global
Regions
WHO Regional websites
Africa
Americas
South-East Asia
Europe
Eastern Mediterranean
Western Pacific
When autocomplete results are available use up and down arrows to review and enter to select.
(...) However, where CBD is produced for pharmaceutical purposes as an extract of cannabis, cannabis extracts and tinctures are included in the 1961 UN Single Convention on Narcotic Drugs. A fuller review of extracts or preparations containing almost exclusively CBD will take place in June 2018, when the WHO expert committee will undertake a comprehensive review of cannabis and cannabis related substances.
Not scheduling a substance means that it is not subject to strict international controls, including for production and supply.
Language:English
Score: 1691501.2
-
https://www.who.int/news-room/...abidiol-(compound-of-cannabis)
Data Source: un
In 2018, WHO’s ECDD carried out a formal review of cannabis and all cannabis-related substances that are currently subject to international control measures. (...) The Committee went on to scientifically review cannabis and other products derived from the cannabis plant, and made a series of recommendations that would more effectively control cannabis preparations with high levels of delta-9-THC (dronabinol), and allow further research and development of and improve access to cannabis-related medicines whilst also minimizing public health problems associated with non-medical cannabis products.
(...) Reclassification of cannabis and cannabis resin will remove some international procedural barriers to research and development of cannabis-based medical products according to national regulatory frameworks.
Language:English
Score: 1498106.4
-
https://www.who.int/news/item/...recognize-its-therapeutic-uses
Data Source: un
Facebook
Twitter
Print
Email
UN commission reclassifies cannabis, yet still considered harmful
2 December 2020
Law and Crime Prevention
In reviewing a series of World Health Organization (WHO) recommendations on cannabis and its derivatives, the Commission on Narcotic Drugs (CND) zeroed-in on the decision to remove cannabis from Schedule IV of the 1961 Single Convention on Narcotic Drugs — where it was listed alongside specific deadly, addictive opioids, including heroin, recognized as having little to no therapeutic purposes.
(...) Tweet URL
Ambassador Khan @ambmansoorkhan, @CND_tweets Chair, opens the 63rd reconvened session – starting with the voting on @WHO scheduling recommendations on cannabis and cannabis-related substances @ UNODC @UN_Vienna. (...) Meanwhile, the United States voted to remove cannabis from Schedule IV of the Single Convention while retaining them in Schedule I, saying it is “consistent with the science demonstrating that while a safe and effective cannabis-derived therapeutic has been developed, cannabis itself continues to pose significant risks to public health and should continue to be controlled under the international drug control conventions”.
Language:English
Score: 1478140.3
-
https://news.un.org/en/story/2020/12/1079132
Data Source: un
The survey found that there is large-scale cannabis cultivation in exactly half of the country’s 34 provinces. Afghanistan’s cannabis crop yields an estimated 145 kilograms per hectare of hashish, the resin produced from cannabis, as compared to around 40 kilograms per hectare in Morocco.
(...) Also like opium, cannabis trading centres are situated throughout the country, UNODC pointed out.
Language:English
Score: 1474192.3
-
https://news.un.org/en/story/2010/03/334142
Data Source: un
Según la Junta, entre los efectos psicosociales a largo plazo del consumo habitual del cannabis, se encuentra, entre otras cosas, la dependencia . (...) Otros riesgos fisiológicos a más largo plazo del consumo habitual del cannabis pueden incluir bronquitis crónica e infartos al miocardio.
(...) Estamos hablando del cannabis medicinal y de fines científicos. El Estado tiene que tomar posesión de la materia, es decir de toda la producción.
Language:English
Score: 1463579.4
-
https://news.un.org/es/audio/2019/03/1452201
Data Source: un
WHO endorses decisions of Expert Committee on cannabis and other substances
Global
Regions
WHO Regional websites
Africa
Americas
South-East Asia
Europe
Eastern Mediterranean
Western Pacific
When autocomplete results are available use up and down arrows to review and enter to select.
(...) Those recommendations include: Cannabis-related substances: The Committee recognized the public health harms presented by these substances, as well as their potential for therapeutic and scientific use. As a result, the Committee recommended a more rational system of international control surrounding cannabis and cannabis-related substances that would prevent drug-related harms whilst ensuring that cannabis-derived pharmaceutical preparations are available for medical use.
Language:English
Score: 1453222.3
-
https://www.who.int/news/item/...-cannabis-and-other-substances
Data Source: un
cannabis | UN News
Skip to main content
Welcome to the United Nations
Language
العربية
中文
English
Français
Русский
Español
Português
Kiswahili
Other
Hindi हिंदी
Global
UN News
Global perspective Human stories
Search
Search
Advanced Search
Main navigation
Home
Africa
Americas
Asia Pacific
Middle East
Europe
UN Art and Gifts
History Corner
Topics
Peace and Security
Economic Development
Humanitarian Aid
Climate and Environment
Human Rights
UN Affairs
Women
Law and Crime Prevention
Health
Culture and Education
SDGs
Migrants and Refugees
In depth
Interviews
Features
Photo Stories
News in Brief
The Lid is On
UN Gender Focus
UN and Africa
UN Podcasts
Secretary-General
Spokesperson
All Statements
Selected Speeches
Press Encounters
Official Travels
Media
UN Video
UN Photo
Meeting Coverage
Media Accreditation
Webtv
Audio and Subscription
Audio Hub
Subscribe
Filter by:
Audio
cannabis
Unsplash/David Gabrić
UN commission reclassifies cannabis, yet still considered harmful
2 December 2020
Law and Crime Prevention
Facebook
Twitter
Print
Email
In reviewing a series of World Health Organization (WHO) recommendations on cannabis and its derivatives, the Commission on Narcotic Drugs (CND) zeroed-in on the decision to remove cannabis from Schedule IV of the 1961 Single Convention on Narcotic Drugs — where it was listed alongside specific deadly, addictive opioids, including heroin, recognized as having little to no therapeutic purposes.
Audio
7'27"
INCB
Canada’s legalization of cannabis ‘contravenes’ international convention: UN drugs control board
15 October 2018
Interviews
Facebook
Twitter
Print
Email
The legalization of cannabis in Canada for recreational-use, contravenes the key International Drug Control Convention , and is “not a healthy” lifestyle choice.
(...) Audio
6'37"
UN Photo/John Robaton
Cannabis use on the rise worldwide
26 June 2015
General News
Facebook
Twitter
Print
Email
Cannabis use is increasing worldwide and evidence shows that what’s available on the market is now more potent than ever before.
Language:English
Score: 1449152.8
-
https://news.un.org/en/tags/cannabis
Data Source: un
This is the first time that the ECDD carries out a full review of cannabis and cannabis-related substances since the International Drug Control Conventions were established in 1961 and 1971. Until now, cannabis has been under the strictest control (schedules 1 and 4) – i.e. at the same level as heroin.
At the meeting, the ECDD is expected to make recommendations about the appropriateness of the current international scheduling of cannabis and cannabis-related substances. The aim of these recommendations is to ensure that international control measures can effectively protect people’s health, in particular the most vulnerable, but do not limit access to cannabis derived products with proven therapeutic properties.
Language:English
Score: 1446156.4
-
https://www.who.int/news/item/...-cannabis-and-other-substances
Data Source: un
MAPS is also sponsoring Phase II trials of smoked whole-plant cannabis for PTSD in veterans in the United States.
(...) In December 2017, WHO stated that cannabis compound cannabidiol (CBD) not be internationally scheduled as a controlled substance. In June 2018, the WHO expert committee began a comprehensive review of cannabis and cannabis-related substances. The final part of the critical review will occur at the 41st Expert Committee on Drug Dependence in November 2018, where WHO is likely to issue recommendations for changing the scheduling status of cannabis, cannabis resin, and cannabis extracts and tinctures.
Language:English
Score: 1444850.8
-
https://www.ohchr.org/sites/de...iationPsychedelicStudies2.docx
Data Source: un
Actualmente, más de 50 países han adoptado programas de cannabis medicinal, mientras que Canadá, Uruguay y 15 estados de Estados Unidos han legalizado su uso recreativo. (...) Mientras tanto, Estados Unidos, que votó por eliminar el cannabis de la Lista IV de la Convención Única, se inclinó por mantenerlo en la Lista I , argumentando que es "coherente con la ciencia que demuestra que, si bien se ha desarrollado un tratamiento derivado del cannabis seguro y eficaz, el cannabis en sí continúa planteando riesgos importantes para la salud pública que deben seguir estando controlados en virtud de las convenciones internacionales de fiscalización de drogas”.
(...) Las noticias del jueves
Existe una epidemia oculta entre las personas mayores: la adicción a las drogas
Cura para el VIH, Cannabis... Las noticias del martes
Quizá también te interese...
Language:English
Score: 1444370.8
-
https://news.un.org/es/story/2020/12/1485022
Data Source: un
